Most Popular - Keryx Biopharmaceuticals (KERX) issued a press release on Thursday morning related to the Medicare bundle for oral-only phosphate binders, which would positively impact the company’s lead candidate … Continue Reading
Read nowLong Ideas - AbbVie (NYSE:ABBV), the R&D-focused spinoff of Abbot Laboratories (NYSE:ABT), began its first day of trading on the NYSE on Wednesday, and we expect shares of … Continue Reading
Read now- Navidea Biopharmaceuticals updated its prospectus on Monday afternoon to include 12.5M common shares owned by Platinum-Montaur Life Sciences, which are now available for resale on the open … Continue Reading
Read nowLong Ideas - It seems that shares of AVEO Oncology (NASDAQ:AVEO) may have finally found their bottom. The oncology drug-developer bounced off of support at $6 (a triple … Continue Reading
Read nowLong Ideas - Halozyme Therapeutics (NASDAQ:HALO) announced that it has licensed the use of its technology platform to Pfizer Inc. (NYSE:PFE) to develop Pfizer’s biologics with Halozyme’s Enhanze … Continue Reading
Read nowLong Ideas - Cornerstone Therapeutics (NASDAQ:CRTX) has renegotiated a distribution agreement with partner and majority shareholder Chiesi Farmaceutici, an Italian pharmaceutical company, which according to the company, should … Continue Reading
Read nowLong Ideas - Updated at 11:00AM, 12/20/12. Shares of Illumina (ILMN) climbed 7% in the pre-market on news that Roche (RHHBY) may have revised higher its previous buy-out … Continue Reading
Read now